Lixte Biotechnology Holdings Inc (LIXT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lixte Biotechnology Holdings Inc (LIXT) has a cash flow conversion efficiency ratio of -0.200x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.83 Million) by net assets ($9.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Lixte Biotechnology Holdings Inc for the company's overall valuation and market capitalisation.
Lixte Biotechnology Holdings Inc - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Lixte Biotechnology Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lixte Biotechnology Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lixte Biotechnology Holdings Inc ranked by their cash flow conversion efficiency. Explore LIXT operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ascot Resources Ltd.
TO:AOT
|
-0.032x |
|
Yatra Online Inc
NASDAQ:YTRA
|
-0.051x |
|
Sanifoam Sunger Sanayi ve Ticaret AS
IS:SANFM
|
-0.008x |
|
Evergreen Corp
NASDAQ:EVGR
|
-0.024x |
|
XCF Global, Inc. Class A Common Stock
NASDAQ:SAFX
|
-1.000x |
|
DarioHealth Corp
NASDAQ:DRIO
|
-0.100x |
|
artnet AG Namens-Aktien o.N.
XETRA:ART
|
0.034x |
|
Swiss Water Decaffeinated Coffee Inc
TO:SWP
|
0.175x |
Annual Cash Flow Conversion Efficiency for Lixte Biotechnology Holdings Inc (2005–2025)
The table below shows the annual cash flow conversion efficiency of Lixte Biotechnology Holdings Inc from 2005 to 2025. View today's stock price for Lixte Biotechnology Holdings Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.96 Million | $-3.07 Million | -0.280x | +92.68% |
| 2024-12-31 | $827.22K | $-3.16 Million | -3.826x | -255.95% |
| 2023-12-31 | $3.99 Million | $-4.29 Million | -1.075x | -20.37% |
| 2022-12-31 | $5.17 Million | $-4.61 Million | -0.893x | -3.24% |
| 2021-12-31 | $4.79 Million | $-4.14 Million | -0.865x | -103.37% |
| 2020-12-31 | $5.01 Million | $-2.13 Million | -0.425x | +38.17% |
| 2019-12-31 | $2.43 Million | $-1.67 Million | -0.688x | -87.80% |
| 2018-12-31 | $4.13 Million | $-1.51 Million | -0.366x | +74.19% |
| 2017-12-31 | $995.04K | $-1.41 Million | -1.419x | +81.83% |
| 2016-12-31 | $214.76K | $-1.68 Million | -7.811x | -11.85% |
| 2015-12-31 | $312.33K | $-2.18 Million | -6.983x | -13.52% |
| 2014-12-31 | $265.86K | $-1.64 Million | -6.152x | -23.17% |
| 2013-12-31 | $236.27K | $-1.18 Million | -4.995x | -518.00% |
| 2012-12-31 | $1.49 Million | $-1.21 Million | -0.808x | +95.30% |
| 2011-12-31 | $79.02K | $-1.36 Million | -17.206x | -3090.42% |
| 2010-12-31 | $1.74 Million | $-936.39K | -0.539x | -9.91% |
| 2009-12-31 | $1.30 Million | $-638.44K | -0.491x | -126.56% |
| 2008-12-31 | $-323.55K | $-597.69K | 1.847x | +199.06% |
| 2007-12-31 | $376.93K | $-702.87K | -1.865x | -163.47% |
| 2006-12-31 | $626.56K | $-443.45K | -0.708x | -116.94% |
| 2005-12-31 | $-7.87K | $-32.87K | 4.177x | -- |
About Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions. It offers plug-and-play battery storage systems integrated into specially designed and patent-pending mobile energy storage systems and docking systems. The company's products include Traveler, a mobile battery energy storage system offering utility-scale power with 1 MW o… Read more